OSTX

0.80302.12%
OE

Olivia Egge

Member of Patient Advocacy Advisory Board

Ms. Olivia Egge is Member of Patient Advocacy Advisory Board of OS Therapies Incorporated from August 2024. Ms. Egge is the Member Board of Directors at Emerita and was Director at OS Therapies Incorporated. Ms. Egge diagnosis with Osteosarcoma (OS) in February 2017, followed by a severe treatment protocol that has not advanced in forty years. Olivia has given us the inspiration to search for new cures for OS, while continually giving us the patient perspective as Osteosarcoma Survivor.

Positions